论文部分内容阅读
目的:观察联合用药治疗社区获得性肺炎的临床效果。方法:选择2012年3月-2014年3月于我院就诊的社区获得性肺炎患者72例,随机将患者分为治疗组与对照组,对照组在常规治疗基础上应用左氧氟沙星进行治疗,治疗组患者在对照组基础上联用莫西沙星进行治疗,比较两组患者的临床治疗效果。结果:治疗组患者治疗有效率与对照组患者相比明显提高,且P<0.05,差异具有统计学意义;治疗组患者与对照组患者间不良反应发生情况并无显著差异,P>0.05,差异不具有统计学意义。结论:联合用药治疗社区获得性肺炎疗效显著,安全性高,具有一定临床推广应用的价值。
Objective: To observe the clinical effect of combination therapy on community-acquired pneumonia. Methods: Seventy-two patients with community-acquired pneumonia who were treated in our hospital from March 2012 to March 2014 were randomly divided into treatment group and control group. The control group was treated with levofloxacin on the basis of routine treatment. The treatment group The patients were treated with moxifloxacin on the basis of the control group, and the clinical effects of the two groups were compared. Results: The effective rate of treatment group was significantly higher than that of the control group, P <0.05, the difference was statistically significant; there was no significant difference between the treatment group and the control group, P> 0.05, the difference Not statistically significant. Conclusion: The combination therapy for community-acquired pneumonia has significant curative effect, high safety and certain clinical application value.